Changes in tiny blood vessels of the eye could be a precursor in determining a higher risk of later narrowing in the large blood vessels in the legs, according to a recent study presented at the American Heart Association's Epidemiology and Prevention/Lifestyle and Cardiometabolic Health 2017 Scientific Sessions.

Consuming more fruits and vegetables could save millions of years lost by those who would otherwise have been disabled or died prematurely from heart disease, according to a recent study presented at the American Heart Association's (AHA) Epidemiology and Prevention/Lifestyle and Cardiometabolic Health 2017 Scientific Sessions. 

Change to the country's health care system will be smoother if current fraud and abuse laws are reformed to improve patient outcomes and reduce costs, according to a white paper released by the Healthcare Leadership Council.

Takeda Pharmaceuticals U.S.A. Inc. and Cognition Kit Limited are partnering to pilot an app for the Apple Watch to monitor and assess cognitive function in patients with major depressive disorder (MDD).

The Food and Drug Administration has accepted The Medicine Co.'s filing for Carbavance, which is used to treat complicated urinary tract infections.

The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of ZS-9 (sodium zirconium cyclosilicate).

The ALS Association's Milton Safenowitz Postdoctoral Fellowship Program has awarded $600,000 in funding to young scientists in the amyotrophic lateral sclerosis (ALS) field. 

The Food and Drug Administration (FDA) has accepted Celgene Corp.'s new drug application for Enasidenib, a treatment for patients with relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase 2 mutation.

NASCAR has designated Lilly Diabetes its official health partner for diabetes.

Pharmaceutical company Boehringer Ingelheim has expanded its collaboration with Vanderbilt University to fight Kirsten Rat Sarcoma viral oncogene (KRAS), a molecular switch that plays a key role in the onset of some of the deadliest cancers.

3M Drug Delivery Systems recently entered a new phase of its collaboration with Panacea Pharmaceuticals Inc. to deliver an investigational therapeutic cancer vaccine. 

Sigma-Tau Pharmaceuticals Inc., a research-based pharmaceutical company, has changed its name to Leadiant Biosciences Inc.

Ferring Pharmaceuticals and Foresee Pharmaceuticals Co. Ltd. have joined forces to take advantage of Foresee Pharmaceuticals' platform for developing specific formulations of a peptide therapeutic.

The Food and Drug Administration has approved AstraZeneca's Qtern, which is taken to help treat Type 2 diabetes.

Aurinia Pharmaceuticals Inc. CEO Richard M. Glickman recently spoke at the Cowen and Company 37th Annual Healthcare Conference in Boston.

Registration is open to attend the National Psoriasis Foundation's (NPF) biennial National Volunteer Conference (NVC) on Aug. 4-5.

Many adults with diabetes are not aware of the increased risk of certain serious illnesses, according to a recent poll sponsored by Merck and conducted by Harris Poll.  

Merck has announced the first Phase 3 study results for V212, the company’s investigational inactivated varicella zoster virus vaccine for the prevention of shingles in immunocompromised patients.

Exelixis and Bristol-Myers Squibb Co. have entered into a clinical development collaboration to evaluate Cabometyx and Opdivo, drugs to treat first-line renal cell carcinoma.

An investigational malaria vaccine has protected a small number of healthy U.S. adults from infection with a malaria strain different from that contained in the vaccine, according to a recent published study.